Disease: Central nervous system (CNS) segment

CYCN		Cyclerion Therapeutics, Inc. - Common Stock			0		+ Medicine, Disease: Central nervous system (CNS)	+ My List
PRAX		Praxis Precision Medicines, Inc. - Common Stock			100% 100% 0		+ Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine	+ My List
RLMD		Relmada Therapeutics, Inc. - Common Stock			-7.62% down -6.98% -0.64		+ Disease: Central nervous system (CNS), Biotechnology, Medicine	+ My List
RVPH		Reviva Pharmaceuticals Holdings, Inc. - Common Stock			104.55% 104.55% 0		+ Medicine, Biopharma, Pharmaceutical , Disease: Metabolic disorders, Disease: Central nervous system (CNS), Respiratory therapies / Pulmanory	+ My List
TNXP		Tonix Pharmaceuticals Holding Corp. - Common Stock			0		+ Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)	+ My List
TRVN		Trevena, Inc. - Common Stock			-7.51% down -6.81% -0.7		+ Biopharma, Medicine, Disease: Central nervous system (CNS)	+ My List
TSHA		Taysha Gene Therapies, Inc. - Common Stock			3.42% up -0.43% 3.85		+ Gene and cell, Disease: Central nervous system (CNS), Medicine	+ My List
TTNP		Titan Pharmaceuticals, Inc. - Common Stock			0		+ Biopharma, Disease: Central nervous system (CNS), Medicine	+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.